US Remote Patient Monitoring (RPM) Market

The US remote patient monitoring (RPM) market is projected to reach USD 29.13 billion by 2030 from USD 16.09 billion in 2025, at a high CAGR of 12.6% during the forecast period. The US remote patient monitoring (RPM) industry is growing efficiently due to the increasing adoption of remote healthcare services by patients and healthcare providers alike, as well as the rising demand for easy and flexible healthcare solutions. Although RPM and telemedicine solutions make it feasible and affordable to provide healthcare by improving the organization of care and decreasing unnecessary hospitalizations and the strain on healthcare organizations and professionals, inconsistencies in the payment structure and adoption framework within federal and state authorities may limit their growth and adoption.

Two prominent strategies propelling the US remote patient monitoring (RPM) market are innovation and collaborations. On the innovation side, many RPM solutions have focused on developing AI-enabled analytics, predictive notifications, and risk stratification. One prominent innovation in the market emerged in February 2025 when Validic, a US digital health company, introduced its generative AI-powered remote patient monitoring assistant through the Validic Impact remote patient monitoring solution. The solution allows the automated analysis of patients’ information and the provision of relevant clinical recommendations. On the other hand, the rise in collaborations in the US remote patient monitoring market is broadening the framework for remote patient monitoring solutions. One prominent collaboration emerged in April 2025 when Tenovi partnered with Validic to enhance the accessibility of remote patient monitoring information through the integration of cellular-connected remote patient monitoring devices with cloud-based data platforms.

To know about the assumptions considered for the study download the pdf brochure

The US remote patient monitoring (RPM) market is dominated by key players. The major players operating in this market are Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Medtronic (Ireland), GE Healthcare (US), Abbott (US), Oracle (US), Boston Scientific Corporation (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), VitalConnect (US), VivaLNK, Inc. (US), Clear Arch, Inc. (US), Optum, Inc. (Vivifyhealth) (US), Blue Spark Technologies, Inc. (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc. (US), Guangdong Transtek Medical Electronics Co., Ltd. (China), Dexcom (US), CareSimple Inc. (Canada), TimeDoc, Inc. (US), MD Revolution Inc. (US), Optimize Health, Inc. (US), and Health Recovery Solutions (US).

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is categorized into four business segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The company focuses on both organic and inorganic growth strategies to expand its market share. Collaborations with the highest-growth markets and partnerships have remained the key growth pillars of Philips. For example, in July 2024, Bon Secours Mercy Health announced a 10-year strategic partnership with Philips to adopt and expand a new patient monitoring solution across its 49 hospitals and 1,200 care sites. Philips collaborates with several leading firms in the healthcare industry, as well as new-age AI startups based in different geographical regions. In July 2025, the company announced a collaboration with Epic Systems to integrate Philips' ambulatory cardiology monitoring and diagnostic offerings into Epic Systems' Aura diagnostics solution. This integration will enable users to view ECG orders and results, as well as observe the Philips ambulatory cardiological interpretations within the Epic Electronic Health Records.

Medtronic (Ireland)

Medtronic is a global health technology company based in Ireland and is a leader in its field. The company serves health systems, physicians, healthcare professionals, and patients in over 150 countries worldwide. Medtronic operates in four main business sectors: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The Cardiovascular segment offers solutions for heart rhythm disorders, cardiac structural issues, and vascular conditions. The Neuroscience division offers a range of solutions for surgeries related to the spinal cord and brain, as well as treatments for brain disorders. The Medical Surgical business focuses on surgical tools, surgical robots to assist in operations, and tools for comprehensive body examinations. The Diabetes division offers innovative products, including insulin pumps, continuous blood sugar monitors, and smart insulin pens, for patients with Type 1 and Type 2 diabetes. In May 2025, Medtronic announced plans to spin off its Diabetes business into an independent, publicly traded company. This decision enables Medtronic to focus on its primary growth areas while allowing the Diabetes division to operate autonomously, facilitating faster innovation in connected diabetes management and remote monitoring solutions.

MARKET RANKING

The US remote patient monitoring (RPM) market is driven by key medical technology companies that offer integrated hardware and software platforms for enabling continuous patient monitoring and proactive patient management.

Koninklijke Philips N.V. is at the forefront through its full range of RPM solutions, including interoperable connected medical devices, cloud-based analytics, and care management platforms, which help patients suffering from chronic conditions and those participating in hospital-at-home programs.

Medtronic enhances the market by providing advanced implantable and wearable monitoring solutions, remote cardiac and chronic care management platforms, and AI-driven data analytics that enable doctors to monitor patients’ conditions in near real-time and take necessary actions before any deterioration in health.

Abbott is contributing through its widely accepted continuous glucose monitoring and connected diagnostic solutions, which allow for seamless remote management of diabetes and cardiac patients.

OMRON Healthcare, Inc. supports the adoption of RPM by ensuring home monitoring options for blood pressure and cardiovascular conditions that are validated in a clinic setting and can be remotely accessed through digital solutions.

GE HealthCare takes it a step further by offering solutions for remote monitoring, predictive analytics, and connectivity that enable integration with hospital systems to capture patient data.

Taken together, these major players provide scalable, interoperable, and highly clinical RPM systems that can improve continuity of care, lower the rate of hospitalization, and enhance the outcomes of healthcare within the US healthcare sector.

Related Reports:

US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com